1. Rötzschke, K. Falk, K. Deres, H. Schild, M. Noda, J. Metzger, G. Jung, and H.-
G. Rammensee (1990).
Isolation and Analysis of Naturally Processed Viral Peptides as Recognized by
Cytotoxic T Cells,
Nature 348, 252-254.
2. K. Falk, O. Rötzschke, S. Stevanovic, G. Jung, and H.-G. Rammensee
(1991).
Allele-Specific Motifs Revealed by Sequencing of Self-Peptides Eluted from
MHC-Molecules,
Nature 351, 290-296.
3. O. Rötzschke, K. Falk, S. Stevanovic, B. Grahovac, M. J. Soloski, G. Jung, and
H.-G. Rammensee (1993).
Qa-2 Molecules are Peptide Receptors of Higher Stringency than Ordinary
Class I Molecules,
Nature 361, 642-644.
4. K. Falk, O. Rötzschke, B. Grahovac, D. Schendel, S. Stevanovic, V. Gnau, G.
Jung, J.L. Strominger, and H.-G. Rammensee (1993).
Allele-Specific Peptide Ligand Motifs of HLA-C Molecules,
Proc. Natl.
Acad. Sci. 90, 12005-12009.
5. N. Zimmermann, O. Rötzschke, K. Falk, D. Rognan, G. Folkers, H.-G. Rammensee,
and G. Jung (1992).
Molecular Modelling of the Class I Human Histocompatibility Molecule HLA-
A2 Presenting an Allele-Specific Nonapeptide from Influenza Matrix Proteiin,
Angew. Chem. 104, 928-931; Angew. Chem. Int. Ed. Engl. 31, 886-
890.
6. K. Falk, O. Rötzschke, M. Takiguchi, B. Grahovac, V. Gnau, S. Stevanovic, G.
Jung, and H.G. Rammensee (1994).
Peptide Motifs of HLA-A1, -A11, -A31, and -A3 Molecules,
Immunogenetics 40, 238-241.
7. K. Falk, O. Rötzschke, S. Stevanovic, V. Gnau, K. Sparbier, G. Jung, H.-G.
Rammensee, and P. Walden (1994).
Analysis of a Naturally Occuring MHC-Class I Restricted Viral Epitope,
Immunol. 82, 337-342.
8. G. Malcherek, V. Gnau, S.Stevanovic, H.-G. Rammensee, G. Jung, and A.Melms
(1994).
Analysis of Allele-Specific Contact Sites of Natural HLA-DR17 Ligands,
J. Immunol. 153, 1141-1149.
9. K. Falk, O. Rötzschke, M. Takiguchi, V. Gnau, S. Stevanovic, G. Jung, and H.-
G. Rammensee (1995).
Peptide Motifs of HLA-B51, -B52 and B-78 Molecules, and Implications for
Behzets Disease,
Int. Immunology 7, 223-228.
10. G. Malcherek, V. Gnau, G. Jung, H.-G. Rammensee, and A. Melms (1995).
Supermotifs Enable Natural Invariant Chain-Derived Peptides to Interact with
Many Major Histocompatibility Complex-Class II Molecules,
J. Exp. Med.
181, 527-536.
11. G. Niedermann, S. Butz, H.-G. Ihlenfeldt, R. Grimm, M. Lucchiari, H.
Hoschützky, G. Jung, B. Maier, and K. Eichmann (1995).
Contribution of Proteasome Mediated Proteolysis to the Hierarchy of Epitopes
Presented by MHC Class I,
Immunity 2, 289-299.
12. K. Falk, O. Rötzschke, M. Takiguchi, V. Gnau, S. Stevanovic, G. Jung, and
H.G. Rammensee (1995)
Peptide Motifs of HLA-B58, B60, B61, and B62 Molecules,
Immunogenetics 41, 165-168.
13. K. Falk, O. Rötzschke, M. Takiguchi, V. Gnau, S. Stevanovic, G. Jung, and
H.G. Rammensee (1995)
Peptide Motifs of HLA-B38 and B39 Molecules,
Immunogenetics 41, 162-164.
14. A. Steinle, K. Falk, O. Rötzschke, V. Gnau, S. Stevanovic, G. Jung,
D.J. Schendel, and H.-G. Rammensee (1996)
Motif of HLA-B
*
3503 Peptide Ligands,
Immunogenetics 43, 105-107.
15. R. Brock, K.-H. Wiesmüller, G. Jung, and P. Walden (1996)
Molecular Basis for the Recognition of Two Structurally Different Major
Histocompatibility Complex/Peptide Complexes by a Single T Cell Receptor,
Proc. Natl. Acad. Sci. USA 93, 13108-13113
16. T. Friede, V. Gnau, G. Jung, W. Keilholz, S. Stevanovic, and H.-G. Rammensee (1996)
Natural Ligand Motifs of Closely Related HLA-DR4 Molecules Predict Features
of Rheumatoid Arthritis Associated Peptides,
Biochim. Biophys. A. 1316, 85-101.
17. B. Fleckenstein, H. Kalbacher, C.P. Muller, D. Stoll, T. Halder, G. Jung, and
K.-H. Wiesmüller (1996)
New Ligands Binding to the Human Leukocyte Antigen Class II Molecule DRB1
*
Based on the Activity Pattern of an Undecapeptide Library,
Eur. J. Biochem. 240, 71-77.
cojinfo@uni-tuebingen.de(cojinfo@uni-tuebingen.de) - July 23, 1997